Comparing seminal plasma biomarkers between normospermic and azoospermic men.
Infertility is a problem that affects more than 10-15% of couples during reproductive years and male factor infertility is the cause of up to half of the cases. (1, 2). Most male factor infertilities are due to testicular failure which results in a decline in semen quality (3). Most male factor infertilities are represented as a wide range of semen quality from normal spermogram to absence of any sperm in semen. The absence of sperm in semen results from sever failure in testicular function or obstruction of extra-testicular ducts (4). Azoospermia, defined as complete absence of spermatozoa in ejaculate, is present in less than 1% of men in the normal population, and 10-15% of infertile men (5). Azoospermia results from obstruction of extratesticular ducts (obstructive) or testicular dysfunction (non-obstructive), (6, 7). In obstructive azoospermia (OA) sperm can be retrieved by microsurgical sperm aspiration (MESA), percutaneous sperm aspiration (PESA), testicular sperm aspiration (TESA) or testicular sperm extraction (TESE) in more than 90% of cycles. Nonobstructive azoospermia (NOA) is caused by severe impairment of spermatogenesis and it is considered the most critical cause of male infertility (7). In men with NOA, only a few foci of spermatogenesis may be present in the testis. In about 30% of NOA cases, sperm can be retrieved after multiple testicular biopsies, however in more than 70% of men with NOA sperm is not found in the testis following multiple biopsies and testis may also be atrophied following these multiple procedures (8). Therefore, prognosis of sperm presence in NOA cases and evidence of its absence in testicular tissue in negative cases have remarkable values in the treatment of male infertility.
Not long ago, prognosis of sperm retrieval in NOA men was mostly limited to physical examinations (testis volume and consistency), hormonal profile and genetic workup, but the final documentation for the presence or absence of sperm retrieval was given via an invasive diagnostic procedure called TESE. Therefore, application of non-invasive methods with a high sensitivity, specificity and predictive value has a great clinical value and it prevents up to more than 70% of testicular biopsies that result in inadequate sperm for ICSI (9).
Seminal plasma results from a mixture of various secretions from different parts of the male reproductive organ (10). Less than 10% of the seminal plasma results from secretion from seminiferous tubules and epididymis (11), therefore, evaluation of semen components and its biochemical characteristics provide valuable non-invasive biomarkers for evaluating the function of different accessory sex glands and seminiferous tubules involved in semen production.
Seminal plasma contains several components with different origins such as inhibin B, Anti-Mullerian hormone (AMH), Neutral alpha glucosidase (NAG) and fructose. Inhibin B could be used as a marker for the identification of spermatogenesis and as an indicator for the level of interruption in spermatogenesis in men with non-obstructive azoospermia (12). Inhibin B in men with normal fertility is higher than men with impaired spermatogenesis. The fact that semen does not contain inhibin B after vasectomy, further confirms the theory that the testis is the main source of this hormone (13). Anti-Mullerian hormone (AMH) is of testicular origin and it is secreted by Sertoli cells in seminiferous tubules (14, 15). NAG has epididymal origin and its measurement in semen is a simple and sensitive method for determining the type of azoospermia (16, 17). Fructose concentration in seminal plasma could indicate ejaculatory duct obstruction and seminal vesicle function or its hypoplasia (18). Therefore, the four aforementioned markers can evaluate different parts of male reproduvtive ducts.
The aim of this study was to compare the classical hormones used to evaluate male infertility (FSH, LH, and testosterone) by the aforementioned new markers of spermatogenesis in men with normospermia and NOA and also to evaluate their correlation with histopathological results in men with NOA.
Materials and Methods
Two-hundred semen samples were collected from infertile men aged 29-43 years, attending Avicenna Infertility Clinic (AIC) affiliated to Avicenna Research Institute (ARI) in Tehran, Iran. Semen samples were collected by masturbation in a sterile wide-mouthed cup. Semen analysis was immediately performed according to WHO guidelines.
Semen samples were centrifuged for 5 minutes at 3,000 rpm. The supernatant seminal plasma was quickly and carefully recovered and put to freeze at -20[degrees] C for upcoming measurements.
The specimens were categorized into two groups according to the results of spermiograms: normospermic (group 1, n = 100) and azoospermic men (group 2, n = 100). Concentrations of fructose, NAG, inhibin B and AMH were determined in the stored seminal plasma. Fructose concentration and NAG activity were measured according to WHO guidelines. For measuring inhibin B and AMH in semen, an antiprotease cocktail in tablet form (complete antiprotease) was added to seminal plasma immediately after thawing. Levels of inhibin B and AMH were determined using the ELISA sandwich method (DSL, USA). Testosterone, follicle stimulating hormone (FSH) and leutinizing hormone (LH) were measured by chemiluminescent immunoassay (Diasorin, Italy).
In the normozoospermic group, measurement of inhibin B and AMH in undiluted seminal plasma revealed values in excess of the maximum amount for the standard curve. Therefore, the samples were diluted to 1:2.
Testis biopsy was performed on 78 out of 100 azoospermic men. Testicular biopsy had been performed earlier for the other patients in elsewhere, therefore mostly had documented histopathological results and were reluctant to undergo the procedure. Sperm extraction was also performed in the azoospermic group. Subsequently, cytological evaluation for the presence of mature sperm in the testis was performed on wet tissue and histopathological evaluation was done for the presence of different lineage of spermatogenic cells on paraffin-embedded tissue blocks by two skilled clinicians including an embryologist and a pathologist, respectively.
All of the statistical analyses were performed by SPSS software, version 13.0. Correlation and intergroup comparison of the values were carried out by linear regression and student t-test. Spearman s rank correlation test was used to assess correlations and non-parametric Mann-Whitney test was used to assess differences between the groups. P-values less than 0.05 were regarded as significant.
The mean ages of the normozoospermic and azoospermic participants were 35.3 [+ or -] 6.2 (ranging from 29 to 42 years) and 36.64 [+ or -] 6.12 years (ranging from 30-42 years), respectively. There were no significant differences concerning the seminal plasma volume, pH and age between the two groups. Sperm parameters in normospermic men have been summarized in Table 1.
The levels of the aforesaid biomarkers in the two groups have been summarized in Table 2. The range of inhibin B and AMH concentration in the seminal plasma were widely dispersed in the two groups of patients. Seminal concentration of NAG, inhibin B and AMH were significantly (p < 0.05) different between the two groups (Table 2).
As shown in Table 2, the normospermic controls presented a significant increase in NAG activity, (OR: 1.07; 95% CI: 1.04-1.1) and concentrations of inhibin B (OR: 1.01; 95% CI: 1.005-1.016) and AMH (OR: 1.63; 95% CI: 1.17-2.28) in comparison with those of the azoospermic group.
There was a significant correlation between fructose (p = 0.009; r = -0.263), neutral [alpha]-glucosidase (p = 0.013; r = 0.261) and inhibin B (p < 0.05; r = 0.381) with sperm count. In addition, NAG, negatively correlated with the concentration of fructose.
A positive correlation was found between concentrations of inhibin B and AMH (p < 0.001, r = 0.795). In addition, NAG had a positive correlation with inhibin B (p < 0.001, r = 0.412) and AMH (p < 0.001, r = 0.489). There was a negative correlation between levels of inhibin B and AMH with serum concentrations of FSH and LH in the azoospermic group.
Mature spermatozoa was retrieved only in eight men following testicular biopsy and despite multiple biopsies on both testes in 70 patient, there were no mature sperm that could be used for ICSI. The seminal inhibin B concentration was significantly different (p < 0.05) between positive and negative outcomes of TESE due to the presence of mature sperm (Table 4). Table 3 shows the histopathological results of testicular biopsies in comparison with the concentrations of FSH and inhibin B. Mature sperm was retrieved only in about 10% of men undergoing testicular biopsy.
When the azoospermic men were categorized according to the presence or absence of mature sperm in testicular biopsies, there were significant differences in inhibin B and AMH concentrations between the two groups. There were no differences regarding the levels of NAG and fructose between the two groups (Table 4).
In about 50% of cases with none-obstructive azoospermia, sufficient number of viable sperm can be retrieved to perform ICSI following testicular biopsy (19). Until recently, prediction of spermatogenesis in testis was performed by looking for several parameters including spermogram, testis volume and consistency and the endocrine profile (LH, FSH and testosterone) but in numerous cases sperm could not be found following multiple biopsy in the face of signs for sperm presence. On the contrary, despite conditions suggestive of a negative result for sperm presence, proper sperm has been found following multiple biopsies (19, 20). These disagreements reveal limitation of these techniques in predicting spermatogenesis status in the testis of azoospermic men.
Lately, some studies suggested a number of new biomarkers to predict the chances of finding proper spermatozoa following multiple testis biopsies, but only the presence of viable spermatozoa at the time of a preliminary diagnostic biopsy appeared to have a strong predictive value for future treatment via ICSI (19, 20). This explains the need to develop a series of noninvasive biomarkers with high predictive values to estimate the presence of mature sperm in the testis.
Several studies with questionable results have focused on the value of serum FSH and inhibin B to predict the status of spermatogenesis in the testis of NOA men, but the number of papers concerning the potential significance of seminal biomarkers of spermatogenesis are very small (21).
The present study compares some spermatogenesis biomarkers in seminal plasma by comparing the classical and newly introduced seminal plasma biomarkers in normospermic and azoospermic men. The results showed a significant difference in alpha-glucosidase, AMH and inhibin B concentrations in the seminal plasma of azoospermic men in comparison with those of normospermic men. Furthermore, seminal inhibin B concentration was significantly different between positive and negative TESE outcomes due to the presence of mature sperm.
The neutral form of [alpha]-glucosidase originates from epididymis and it is totally absent in the accessory glands and in the testis; but an acidic isoenzyme can be detected in these organs (22). In this study, selective inhibitors were not used to separate neutral and acidic isoenzymes, but the assays were run at neutral pH, which should have inhibited the acidic isozyme, since it is highly sensitive to environmental pH (22).
Guerin et al. showed that patients with azoospermia presented significantly decreased NAG activity. In the present study, NAG activity decreased significantly in azoospermic men compared to normospermic men. Being in agreement with the findings of Henkel et al. , a significant correlation was noted between neutral [alpha]-glucosidase and sperm concentration in our study (23). In addition, Sandoval showed spermatogenesis arrest in NOA men to be associated with a decrease in [alpha]-glucosidase which was lower than the concentration seen in obstructive azoospermia (24). Duan's results on [alpha]-glucosidase in seminal plasma were similar to the findings of the present study and they were closely related to non-obstructive azoospermia. (25).
The present results on fructose confirm previous reports that fructose concentration is negatively correlated with sperm count. The results are in agreement with those of Gonzales et al., who showed that seminal fructose concentration was inversely correlated with sperm count (26). These relationships can be related to the uptake of fructose by spermatozoa. Indeed, fructose present in the seminal plasma is considered as the main source of energy for sperm metabolism and motility in vitro (27). The first report on the increased seminal plasma fructose in samples from men with non-obstructive azoospermia was published by Buckett et al. , who postulated that the condition might be due to a decreased fructose metabolism in the absence of spermatozoa or, more likely, an increased fructose secretion by seminal vesicles (28).
Changes in seminal plasma concentrations of both AMH and inhibin B are inter-correlated. Reaffirming previous findings, a significant positive correlation was observed between inhibin B concentration in the seminal plasma and sperm count, but such correlation was not the case for AMH (29). Moreover, inhibin B and AMH levels negatively correlated with serum FSH and LH concentrations which is in lines with previous studies (14, 30).
The higher concentration of seminal AMH in normospermic men compared with azoospermic subjects is also in agreement with previous studies (29, 31). AMH is preferentially secreted by Sertoli cells into the seminiferous lumen. However, the presence of developmentally more advanced spermatogenic cells may increase AMH secretion that is related to specific stages of the seminiferous epithelium cycle (32). According to the present study, a significant decrease in seminal plasma AMH is associated with the absence of spermatozoa in the semen of azoospermic men, revealing a close correlation between AMH concentration and progress in spermatogenesis. Undetectable seminal AMH in some normospermic men may be due to the presence of seminal proteases and their none-specific digestion of seminal protein content prior or during deep freezing of semen before biochemical analysis (29, 31).
In 11.5% of azoospermic men mature sperm was found following testicular sperm extraction (TESE), but it was much lower than other studies (31). This difference might be due to the more solid techniques used in those studies, such as testicular fine needle aspiration, multiple biopsies from different regions of testis, enzymatic digestion of biopsied seminiferous tubules and micro-dissection TESE (33). The present results support insufficiency of TESE in excluding the absence of focal spermatogenesis in testis of NOA men. Tsujimura et al. , compared multiple TESE and microdissection TESE in 37 and 56 azoospermic men, and the rates of sperm retrieval were 35.1% and 42.9%, respectively (34).
No correlations were found between seminal plasma AMH, NAG, fructose and sperm retrieval, confirming the results of previous studies (29, 31, 35). It was also found that seminal plasma inhibin B in normozoospermic men was significantly higher than that of azoospermic subjects, sustaining the relation between inhibin B secretion and sperm concentration. Harmonious to previous studies, it also demonstrates a positive correlation between the concentrations of inhibin B and AMH with the levels of [alpha]-glucosidase in seminal plasma (30). In contrast to Yehia, Tunc and Duvilla results, a significant difference was noted in seminal plasma inhibin B concentration (p < 0.01) between positive and negative TESE outcomes (29, 30, 36). But the present study confirms Ballesca's findings in this regard (37).
Similar to Yehia's study, the present findings showed higher levels of inhibin B in azoospermic samples with maturation arrest at advanced stages of spermatogenesis compared to samples without any germ cells (Sertoli cell only syndrome or germ cell aplasia), (30). Sertoli cells are the predominant site for the production of inhibin B in the testis (38, 39). By using specific monoclonal antibodies against its [alpha]- and [beta]B-subunits, Andersson et al. revealed that germ cells (but not Sertoli cells), could be immunostained for [beta]B-subunit. Sertoli cells only contain [alpha]-subunits whereas the [beta]B-subunits are localized in pachytene spermatocytes and in round spermatids (38). Therefore, these data discard the hypothesis that Sertoli cells are the only source of inhibin B in testis. It seems that biologically inactive [alpha]-subunits can only be found in the absence of germ cells in mature testis (Sertoli cell-only syndrome or germ cell aplasia). Seemingly, inhibin B is produced by Sertoli cells but its biological activity is dependent on the presence of specific germ cells. Pachytene spermatocytes and round spermatids may act as major modulators for inhibin synthesis in the early stages of sperm development (38, 40).
The present study revealed a significant relationship between levels of inhibin B and AMH in seminal plasma and presence of mature sperm in the testis of NOA men. This finding suggests that inhibin B and AMH are sensitive biomarkers in semen and could reflect the functional state of the seminiferous epithelium. Since inhibin B and AMH determinations are of a low cost and a valuable non-invasive predictor of spermatogenesis, their application is suggested in all NOA men. Serum and seminal plasma levels of inhibin B and AMH, in conjunction with serum FSH will be measured prior to performing TESE. In addition, more attention should be paid to the function of Sertoli and spermatogenic cells in NOA men via application of high throughput techniques to find new specific biomarkers with high sensitivity and specificity.
The authors would like to kindly thank Dr. Hojjat Zeraati and Dr. Kourosh Kamali for statistically revising the text and Avicenna Research Institute for supporting this research financially.
Received: Oct. 16, 2009
Accepted: Dec. 23, 2009
(1.) Sharlip ID, Jarow JP, Belker AM, Lipshultz LI, Sigman M, Thomas AJ, et al. Best practice policies for male infertility. Fertil Steril. 2002;77(5):873-82.
(2.) Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, Lansac J, et al. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Hum Reprod. 1991;6(6):811-6.
(3.) Brugh VM 3rd, Lipshultz LI. Male factor infertility: evaluation and management. Med Clin North Am. 2004;88(2):367-85.
(4.) Song GJ, Lee H, Park Y, Lee HJ, Lee YS, Seo JT, et al. Expression pattern of germ cell-specific genes in the testis of patients with nonobstructive azoospermia: usefulness as a molecular marker to predict the presence of testicular sperm. Fertil Steril. 2000;73 (6):1104-8.
(5.) Jarow JP, Espeland MA, Lipshultz LI. Evaluation of the azoospermic patient. J Urol. 1989;142(1):62-5.
(6.) Anguiano A, Oates RD, Amos JA, Dean M, Gerrard B, Stewart C, et al. Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA. 1992;267(13):1794-7.
(7.) Sobek A, Hrbkova K, Mucha Z, Vodicka J, Tesarova M, Zat'ura F, et al. Infertility treatment of men with non-obstructive azoospermia. Acta Univ Palacki Olomuc Fac Med. 1998;141:83-5.
(8.) Mercan R, Urman B, Alatas C, Aksoy S, Nuhoglu A, Moldenhauer JS, et al. Outcome of testicular sperm retrieval procedures in non-obstructive azoospermia: percutaneous aspiration versus open biopsy. Hum Reprod. 2000;15(7):1548-51.
(9.) Moldenhauer JS, Ostermeier GC, Johnson A, Diamond MP, Krawetz SA. Diagnosing male factor infertility using microarrays. J Androl. 2003;24(6): 783-9.
(10.) Kumanov P, Nandipati KC, Tomova A, Robeva R, Agarwal A. Significance of inhibin in reproductive pathophysiology and current clinical applications. Reprod Biomed Online. 2005;10(6):786-812.
(11.) Jenkins AD, Turner TT, Howards SS. Physiology of the male reproductive system. Urol Clin North Am. 1978;5(3):437-50.
(12.) Andersson AM. Inhibin B in the assessment of seminiferous tubular function. Baillieres Best Pract Res Clin Endocrinol Metab. 2000;14(3):389-97.
(13.) Blumenfeld Z, Ritter M. Inhibin, activin, and follistatin in human fetal pituitary and gonadal physiology. Ann N Y Acad Sci. 2001;943:34-48.
(14.) Fujisawa M, Yamasaki T, Okada H, Kamidono S. The significance of anti-Mullerian hormone concentration in seminal plasma for spermatogenesis. Hum Reprod. 2002;17(4):968-70.
(15.) Rey R. Assessment of seminiferous tubule function (anti-mullerian hormone). Baillieres Best Pract Res Clin Endocrinol Metab. 2000;14(3):399-408.
(16.) Mahmoud AM, Geslevich J, Kint J, Depuydt C, Huysse L, Zalata A, et al. Seminal plasma alpha-glucosidase activity and male infertility. Hum Reprod. 1998;13(3):591-5.
(17.) Zopfgen A, Priem F, Sudhoff F, Jung K, Lenk S, Loening SA, et al. Relationship between semen quality and the seminal plasma components carnitine, alpha-glucosidase, fructose, citrate and granulocyte elastase in infertile men compared with a normal population. Hum Reprod. 2000;15(4):8405.
(18.) Aumuller G, Riva A. Morphology and functions of the human seminal vesicle. Andrologia. 1992;24 (4):183-96.
(19.) Tournaye H, Verheyen G, Nagy P, Ubaldi F, Goossens A, Silber S, et al. Are there any predictive factors for successful testicular sperm recovery in azoospermic patients? Hum Reprod. 1997;12(1): 80-6.
(20.) Ezeh UI, Taub NA, Moore HD, Cooke ID. Establishment of predictive variables associated with testicular sperm retrieval in men with non-obstructive azoospermia. Hum Reprod. 1999;14(4): 1005-12.
(21.) El Garem YF, El Arini AF, El Beheiry AH, Zeid SA, Comhaire FH. Possible relationship between seminal plasma inhibin B and spermatogenesis in patients with azoospermia. J Androl. 2002;23(6): 825-9.
(22.) Paquin R, Chapdelaine P, Dube JY, Tremblay RR. Similar biochemical properties of human seminal plasma and epididymal alpha-1,4-glucosidase. J Androl. 1984;5(4):277-82.
(23.) Henkel R, Maass G, Schuppe HC, Jung A, Schubert J, Schill WB. Seasonal changes of neutral alpha-glucosidase activity in human semen. J Androl. 2006;27(1):34-9.
(24.) Sandoval L, Diaz M, Rivas F. Alpha-1,4-glucosidase activity and the presence of germinal epithelium cells in the semen for differential diagnosis of obstructive and nonobstructive azoospermia. Arch Androl. 1995;35(2):155-8.
(25.) Duan L, Er X, Zhao J, Duan L, Liu Q, Liu R, et al. [Analysis of the relative etiology of non-obstructive azoospermia]. Zhonghua Nan Ke Xue. 2004;10 (8):616-8, 622. Chinese.
(26.) Gonzales GF, Garcia-Hjarles MA, Gutierrez R, Guerra-Garcia R. The secretory activity of the seminal vesicles and its relationship to sperm motility: effects of infection in the male reproductive tract. Int J Androl. 1989;12(4):286-94.
(27.) Mann T. Fructose, polyols, and organic acids. In: Nam T, editor. The Biochemistry of Semen and of the Male Reproductive Tract. London: Methuen & Co. Ltd; 1964. p. 273-44.
(28.) Buckett WM, Lewis-Jones DI. Fructose concentrations in seminal plasma from men with nonobstructive azoospermia. Arch Androl. 2002;48(1): 23-7.
(29.) Duvilla E, Lejeune H, Trombert-Paviot B, Gentil-Perret A, Tostain J, Levy R. Significance of inhibin B and anti-Mullerian hormone in seminal plasma: a preliminary study. Fertil Steril. 2008;89(2):444-8.
(30.) El Garem YF, El Arini AF, El Beheiry AH, Zeid SA, Comhaire FH. Possible relationship between seminal plasma inhibin B and spermatogenesis in patients with azoospermia. J Androl. 2002;23(6): 825-9.
(31.) Fenichel P, Rey R, Poggioli S, Donzeau M, Chevallier D, Pointis G. Anti-Mullerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum Reprod. 1999;14(8): 2020-4.
(32.) Baarends WM, Hoogerbrugge JW, Post M, Visser JA, De Rooij DG, Parvinen M, et al. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression during postnatal testis development and in the adult testis of the rat. Endocrinology. 1995;136 (12):5614-22.
(33.) Aydos K, Demirel LC, Baltaci V, Unlu C. Enzymatic digestion plus mechanical searching improves testicular sperm retrieval in non-obstructive azoospermia cases. Eur J Obstet Gynecol Reprod Biol. 2005;120(1):80-6.
(34.) Tsujimura A, Matsumiya K, Miyagawa Y, Takao T, Fujita K, Koga M, et al. Prediction of successful outcome of microdissection testicular sperm extraction in men with idiopathic nonobstructive azoospermia. J Urol. 2004;172(5 Pt 1):1944-7.
(35.) Mostafa T, Amer MK, Abdel-Malak G, Nsser TA, Zohdy W, Ashour S, et al. Seminal plasma anti-Mullerian hormone level correlates with semen parameters but does not predict success of testicular sperm extraction (TESE). Asian J Androl. 2007; 9(2):265-70.
(36.) Tunc L, Kirac M, Gurocak S, Yucel A, Kupeli B, Alkibay T, et al. Can serum Inhibin B and FSH levels, testicular histology and volume predict the outcome of testicular sperm extraction in patients with non-obstructive azoospermia? Int Urol Nephrol. 2006;38(3-4):629-35.
(37.) Ballesca JL, Balasch J, Calafell JM, Alvarez R, Fabregues F, de Osaba MJ, et al. Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia. Hum Reprod. 2000;15(8):1734-8.
(38.) Anderson RA, Irvine DS, Balfour C, Groome NP, Riley SC. Inhibin B in seminal plasma: testicular origin and relationship to spermatogenesis. Hum Reprod. 1998;13(4):920-6.
(39.) Young J, Couzinet B, Chanson P, Brailly S, Loumaye E, Schaison G. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. J Clin Endocrinol Metab. 2000;85(9):3239-44.
(40.) Anderson RA. Clinical studies: inhibin in the adult male. Mol Cell Endocrinol. 2001;180(1-2):109-16.
Sabetian, Soudabeh (M.Sc.) ; Ardekani, Ali M. (Ph.D.) ; Hodjat, Mahshid (M.Sc.) ; Akhondi, Mohammad Mehdi (Ph.D.) ; Soltanghoraee, Haleh (M.D.) ; Amirjannati, Naser (Ph.D.) ; Lakpour, Niknam (M.Sc.) ; Sadeghi, Mohammad Reza (Ph.D.)  *
[1-] Department of Biology, Islamic Azad University, Science and Research Branch, Tehran, Iran
[2-] Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
[3-] Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
* Corresponding Author:
Dr. Mohammad Reza
Sadeghi, Reproductive Biotechnology Research Center, Avicenna
Research Institute, ACECR, Tehran, Iran.
Table 1. Sperm parameters in 100 normospermic men attending Avicenna Infertility Clinic Parameters Values Sperm concentration (x [10.sup.6]/ml) 115.0 [+ or -] 69.9 Total sperm count (x [10.sup.6]/ml) 422.2 [+ or -] 288.1 Normal morphology (%) 19.8 [+ or -] 5.9 Motility (%) 80.2 [+ or -] 5.9 grade a 20.1 [+ or -] 9.2 grade b 27.2 [+ or -] 6.7 grade c 10.7 [+ or -] 4.4 WBC (x [10.sup.6]/ml) 0.09 [+ or -] 0.02 -- The reported parameters have been presented as M [+ or -] SD Table 2. Comparing biochemical parameters between normospermic and azoospermic men attending Avicenna Infertility Clinic Variables Azoospermic Normospermic Neutral a-glucosidase 14.1 [+ or -] 10.7 25.6 [+ or -] 16.3 (mU/ml) Fructose (mg/dl) 263.1 [+ or -] 89.8 283.4 [+ or -] 98.1 Inhibin B (pg/ml) 88.6 [+ or -] 129.9 629 [+ or -] 965.2 AMH (ng/ml) 0.7 [+ or -] 3.1 5.5 [+ or -] 7.5 FSH (mIU/ml) 24.4 [+ or -] 18.0 -- LH (mIU/ml) 9.0 [+ or -] 5.6 -- Testosterone (ng/ml) 7.2 [+ or -] 2.5 -- -- The reported parameters have been presented as M [+ or -] SD -- Mann-Whitney Table 3. Histopathological results of testicular biopsies in azoospermic men in comparison with their serum FSH and inhibin B concentrations Histopathological Patients Inhibin B results No.) (ng/ml) Germ cell aplasia 47 57.137 [+ or -] 50.34 Arrest in 23 236.94 [+ or -] 242.138 spermatogenesis Hypospermatogenesis 8 65.83 [+ or -] 63.62 Histopathologicalx FSH results (mIU/ml) Germ cell aplasia 26.87 [+ or -] 17.85 Arrest in 14.02 [+ or -] 17.83 spermatogenesis Hypospermatogenesis 31.08 [+ or -] 17.49 -- Mann-Whitney Table 4. Comparing seminal plasma biomarkers with histopathological results from testicular biopsies in azoospermic men Seminal biomarkers TESE outcome Inhibin B (pg/ml) NAG (mU/ml) Positive 133.69 [+ or -] 60.5 17.68 [+ or -] 10.78 Negative 81.32 [+ or -] 139.76 15.08 [+ or -] 10.76 Seminal biomarkers TESE outcome AMH (ng/ml) Fructose (mg/dl) Positive 0.022 [+ or -] 0.038 255.67 [+ or -] 161.12 Negative 0.9 [+ or -] 3.31 263.86 [+ or -] 84.71 --The reported parameters have been presented as Mean [+ or -] SD -- Mann-Whitney
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Original Article|
|Author:||Sabetian, Soudabeh; Ardekani, Ali M.; Hodjat, Mahshid; Akhondi, Mohammad Mehdi; Soltanghoraee, Haleh|
|Publication:||Journal of Reproduction and Infertility|
|Date:||Mar 1, 2010|
|Previous Article:||Association of Vascular Endothelial Growth Factor (VEGF) +405 G>C polymorphism with endometriosis in an Iranian population.|
|Next Article:||Serum leptin levels in women with immunological recurrent abortion.|